%0 Journal Article
%A Cuadari, Arben
%A Pollastro, Federica
%A Unciti-Broceta, Juan D.
%A Caprioglio, Diego
%A Minassi, Alberto
%A Lopatriello, Annalisa
%A Munoz, Eduardo
%A Taglialatela-Scafati, Orazio
%A Appendino, Giovanni
%T The dimerization of Delta(9)-tetrahydrocannabinolic acid A (THCA-A)
%D 2019
%@ 2211-3835
%U http://hdl.handle.net/10668/18708
%X The renewed interest in dimeric salicylates as broad-spectrum anti-inflammatory and antidiabetic agents provided a rationale to investigate the dimerization of the substituted salicylate Delta(9)-tetrahydrocannabinolic acid (THCA-A, 3a) as a strategy to solve its instability to decarboxylation and to generate analogues and/or pro-drugs of this native pre-cannabinoid. Activation of the carboxylic group with the DCC-HOBt-DMAP protocol afforded a high yield of the OBt ester 4, that was next converted into the highly crystalline di-depsidic dimer 5 upon treatment with DMAP. The mono-depsidic dimer 6 was also formed when the reaction was carried out with partially decarboxylated THCA-A samples. The structure of the depsidic dimers was established by spectroscopic methods and by aminolysis of 5 into the pre-cannabinoid amide 7. Both dimers showed excellent shelf stability and did not generate significant amounts of Delta(9)-THC upon heating. However, only the didepsidic dimer 5 activated PPAR-gamma, the major target of pre-cannabinoids, but strong binding to serum proteins abolished this activity, also shielding it from the action of esterases. (C) 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. 
%K Phytocannabinoids
%K Dimerization
%K Delta(9)-tetrahydrocannabinolic acid A
%K Delta(9)-tetrahydrocannabinol
%K PPAR-gamma
%K Salsalate
%K Drug
%~